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Abstract The cystic fibrosis transmembrane conductance
regulator (CFTR), the defective protein in cystic fibrosis, is
an anion channel activated by protein kinase A phosphor-
ylation. The regulatory domain (RD) of CFTR has multiple
phosphorylation sites, and is responsible for channel acti-
vation. This domain is intrinsically disordered, rendering
the structural analysis a difficult task, as high-resolution
techniques are barely applicable. In this work, we obtained
a biophysical characterization of the native and phosphor-
ylated RD in solution by employing complementary
structural methods. The native RD has a gyration radius of
3.25 nm, and a maximum molecular dimension of 11.4 nm,
larger than expected for a globular protein of the same
molecular mass. Phosphorylation causes compaction of the
structure, yielding a significant reduction of the gyration
radius, to 2.92 nm, and on the maximum molecular
dimension to 10.2 nm. Using an ensemble optimization
method, we were able to generate a low-resolution, three-
dimensional model of the native and the phosphorylated
RD based on small-angle X-ray scattering data. We have
obtained the first experiment-based model of the CFTR
regulatory domain, which will be useful to understand the
molecular mechanisms of normal and pathological CFTR
functioning.
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Introduction
The cystic fibrosis transmembrane conductance regulator
(CFTR/ABCC7) protein is a cAMP-activated anion chan-
nel that belongs to the ATP-binding cassette transporter
super-family. CFTR is expressed in the apical membrane of
epithelial cells in mammalian airways, intestine, pancreas,
and testis. Cystic fibrosis (CF) is a severe genetic disease
caused by more than a thousand naturally occurring
mutations, distributed along the entire CFTR gene. The
CFTR protein is composed of five distinct parts: two
membrane-spanning domains, two nucleotide-binding
domains, and a regulatory region. The channel is activated
by cAMP-dependent phosphorylation of the regulatory
domain (RD), and ATP binding and hydrolysis at the
NBDs are responsible for CFTR pore gating. The RD is
about 185 residues segment, and contains 12 putative ser-
ine-phosphorylation sites. In a fully phosphorylated
protein, between eight and nine phosphoserines have been
detected by mass spectrometry [24, 36] and NMR [3].
Relatively little is known about the structure of the RD,
although it has been predicted to be mostly disordered [26],
a hypothesis that is consistent with NMR data for the
separately expressed and purified RD peptide [3]. The
intrinsic disordered nature of the protein, as well as the lack
of a homology template, has resulted in a great difficulty to
predict the three-dimensional structure of the RD, obtain-
ing several divergent molecule models [14, 21, 22, 29].
Indeed, other whole-CFTR proposed models, where the
pore structure is carefully studied, have neglected the RD
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due to the difficulties of modeling this domain [1, 7, 25].
Electron microscopy has identified the location for some of
RD epitopes in the full-length CFTR protein [44, 45].
NMR data mapped the residue parts involved in the
interactions between the isolated RD with isolated CFTR
nucleotide-binding domains [3, 16]. Phosphorylation of RD
may induce changes on the structural conformation of the
isolated protein, as revealed by circular dichroism [9] and
NMR [3], and may change the interactions between RD
and the NBDs [6, 16].
We have investigated the molecular structure of the
isolated and purified RD in the native, non-phosphorylated
state and in a fully phosphorylated state. We have
employed small-angle X-ray scattering (SAXS), in com-
bination with other biophysical techniques to obtain
structural models of the native and the phosphorylated
CFTR regulatory domain in solution.
Materials and methods
Primary structure analysis
The sequence of the RD was analyzed with the use of the
program metaPrDOS [15] to identify regions of disorder.
This program uses the following seven prediction algo-
rithms to predict disordered regions: PrDOS, DISOPRED2,
DisEMBL, DISPROT(VSL2), DISpro, IUpred, and POO-
DLE-S to optimize the ROC (receiver operating
characteristic) value to minimize the prediction false-
positive rate to less than 5.0 % (see http://prdos.hgc.jp).
Expression and purification of R region
Escherichia coli BL21 (DE3) CodonPlus RIL cells (Strat-
agene) were transformed with a plasmid based on the
pPROEX HTb vector (Invitrogen), encoding a 185-residue
fragment, from position 654–838, of the human CFTR
(UniProtKB P13569) RD, with an N-terminal His6 tag (the
construct was generously provided by J.D. Forman-Kay,
SickKids Hospital, Toronto, ON, Canada). The exact
boundaries of the RD remain a point of discussion (for a
review, see [39]). Here, the Ser654 N-terminal boundary
was chosen to include the PKA phosphorylation consensus
residues on the N-terminal side of the important Ser660
phosphorylation site, as well as Ser654, which is homolo-
gous to the Thr654 residue found to act as an N-terminal
helix cap in the murine NBD1 crystal structure [18]. The
C-terminal boundary was chosen to include a group of
negatively charged residues with a helical propensity sug-
gested to have a functional role in CFTR channel inhibition
[43]. The RD sequence carried the polymorphism Leu833
from the original CFTR cloning paper, as the wild-type
Phe833 was deleterious for protein solubility [3]. Com-
parison of NMR data of RD proteins bearing Phe833 and
Leu833 showed similar structural properties for the two
proteins [3].
Transformed E. coli were grown to A600 & 0.6–0.8 and
induced with 1 mM IPTG for 4–6 h at 37 C. The RD was
purified from the insoluble lysate fraction using a 6 M
guanidinium-HCl purification including Ni2? affinity
chromatography (HisTrap, GE-Healthcare, Uppsala, Swe-
den) and denaturing size exclusion chromatography (SEC)
on a Superdex 75 column (GE-Healthcare), followed by
ionic exchange chromatography. The purified protein was
then dialyzed in two steps: first, against 3 M guanidinium-
HCl, 20 mM TRIS pH 8, 200 mM NaCl, 2 mM DTT; then,
against 30 mM phosphate buffer pH 8, 200 mM NaCl,
2 mM DTT. The product was then concentrated to
*2.5 mg ml-1 by ultra-filtration (Amicon Ultra-10K,
Millipore Corporation, Bedford, MA, USA), fast-frozen in
liquid nitrogen, and stored at -80 C for further use. All
purification and refolding procedures were done at 6–8 C.
For all successive experiments, RD were freshly thawed,
cleared with a 0.45-lm filter (Ultrafree-MC, Millipore) and
protein concentration was estimated by the absorbance at
280 nm (e = 12,210 Mol-1 cm-1).
Western blot
Proteins (10–15 lg) were subjected to SDS polyacrylamide
gel electrophoretic analysis. Separated proteins were then
transferred to PVDF membrane (Millipore, Billerica, MA,
USA) for 1 h at 100 V in a temperature-stable room at
5 C. The blot was then incubated with polyclonal rabbit
anti-RD (1:1,000, Acris Antiboby GmbH, Herford, Ger-
many) and with horseradish peroxidase-conjugated goat
anti-rabbit antibody (1:4,000, Santa Cruz Biotechnology,
Santa Cruz, CA, USA), as secondary antibody using the
SNAP i.d. system (Millipore catalog n WBAVDBASE,
Worcester, MA, USA) according to the manufacturer’s
instructions. Immunodetection was performed using ECL
PLUS detection reagents (GE-Healthcare) and the images
were captured by using Hyperfilm ECL (GE-Healthcare).
Phosphorylation
The catalytic fraction of protein kinase A (PKA, Biaffin
GmbH and Co KG), at a concentration of 600 units per nM
of protein, was added to an aliquot of 10–20 ll of RD
(2–3 mg ml-1) supplemented with 50 lM ATP and 5 mM
MgCl2. The mixture was incubated for 30–40 min at 37 C
and then diluted (to a concentration of 0.1–1 mg ml-1)
with 30 mM phosphate buffer (pH 8.0) supplemented with
1:3,000 of 2-mercaptoethanol. The native RD sample was
prepared in the same way without the addition of PKA.
924 C. Marasini et al.
123
Circular dichroism and fluorescence spectra
The circular dichroism (CD) spectra were acquired on a
Jasco J-815 spectropolarimeter. Step scans were collected
from 195 to 260 nm at 50 nm min-1 with a data pitch of
0.1 nm, in a 0.1 cm rectangular cell. The spectra of the
native and phosphorylated protein were collected (ten
replicate spectra per sample) at 10 C, and normalized to
the concentration of the sample (0.1–0.5 mg ml-1) esti-
mated immediately before the experiment, measuring the
absorbance of the sample at 280 nm. The secondary
structure analysis was done by the on line server Dichro-
web [41], using the algorithm SELCON3 [30].
Fluorescence spectra were done in a Perkin-Elmer LS
50D spectrofluorometer. The native or phosphorylated RD
samples (0.1–0.5 mg ml-1) were excited at 295 or 274 nm,
and the emission spectra were recorded between 300 and
400 nm. Data were obtained as the average of four spectra.
Size exclusion chromatography
We performed analytical gel filtration with a Superdex 75
column to determine the molecular mass of RD by com-
paring its elution volume (Ve) with that of reference proteins.
The void volume (V0) was determined with Dextran blue.
We determined the Stokes radius (RS) of RD using a linear
calibration plot of [-log (Kav)]
1/2 against the Strokes
hydrostatic radius of the standards [35, 38], where Kav is the
partition coefficient, defined as (Ve – V0)/(Vt – V0), with Vt
being the total volume of the column.
SAXS data collection and processing
Small-angle X-ray scattering spectra of 0.8 to 1.6 mg ml-1
of phosphorylated and native RD were collected at the
ID14-EH3 beam line of the European Synchrotron Radia-
tion Facility (ESRF, Grenoble). The sample-detector
distance of 1.83 m covered the range of momentum
transfer 0.08 \ s \ 4.5 nm-1 (s = 4p sin (h)/k, where 2h
is the scattering angle and k = 0.093 nm is the X-ray
wavelength; the optical path of the X-ray through the
sample is about 1 mm). Data were collected at 10 C. For
each sample, we recorded ten spectra of 30 s each, for a
total of 5 min of acquisition. A low concentration of
glycerol (\1.5 %) was used as free radical scavenger to
minimize the radiation damage of the sample. The com-
parison of the ten successive exposures of an acquisition
experiment indicated no changes in the scattering patterns,
i.e., no measurable radiation damage to the protein sam-
ples. Data were normalized to the intensity of the
transmitted beam, and the scattering data from the buffer
(identical to that of the sample) without protein, done
before and after each sample measurement, was averaged
and used to subtract the background.
We processed the data using standard procedures for
ATSAS programs [27]. The forward scattering I(0) and the
radius of gyration Rg were computed using the Guinier
approximation for sRg \ 1.3 [10, 13]. The excluded vol-
ume of the particle, V, was computed using the Porod
equation [10, 13]. The distance distribution function
P(r) was calculated using the indirect Fourier transform
method implemented in the program GNOM [32]. It was
limited to s B 2.5 nm-1, to avoid the high noise found for
larger s. P(r) represents the probability of finding a point
within the observed particle at a distance, r, from a defined
point of reference. Sample molecular mass was estimated
by comparing the extrapolated forward scattering I(0) to a
reference solution made of bovine serum albumin. A Kra-
tky plot was employed to qualitatively assess the overall
conformational state of the native and phosphorylated RD
[12, 38].
Structural modeling of the SAXS data
To obtain quantitative estimates of the degree of the
dynamics and conformational heterogeneity or the RD in
its two conditions, native and phosphorylated, we analyzed
the SAXS data using an ensemble optimization method
(EOM) [4]. Using this strategy, the experimental SAXS
profile is assumed to derive from a (undetermined a priori)
number of coexisting conformational states. A sub-
ensemble of conformations is selected by a genetic algo-
rithm from the scattering patterns computed from a large
pool representing the maximum flexibility allowed by the
protein topology [4].
The optimization was done with the program GAJOE
(Genetic Algorithm Judging Optimization of Ensembles)
that uses a genetic algorithm for the selection of an
ensemble of models, whose combined theoretical scattering
intensity best describe the experimental SAXS data [5].
The program is executed following the generation of a
random pool of models using RANCH to generate a pool of
10,000 native-like random chains structures, where CA-
angle distribution consistent with folded proteins, and
calculated the scattering curve of each structure with the
use of CRYSOL [31]. Each of the experimental SAXS
curves, from native and from phosphorylated RD, was
analyzed with a genetic algorithm (of the best of 50 subsets
of *20 protein structures such that the discrepancy (the v2
value) between the average scattering of the ensemble
model and the experimental data was minimized. For each
curve, ten independent EOM runs were performed, and the
obtained subsets were analyzed to yield the Rg and Dmax.
The low-resolution ab initio shape of native and phos-
phorylated RD was reconstructed with the use of DAMMIF
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[11]. Compact models of interconnected beads were used
to represent the molecule, and simulated annealing was
employed to minimize the discrepancy between the
experimental and calculated data. Fifteen DAMMIF mod-
els were generated for each RD experimental condition and
analyzed using DAMAVER [40], which characterizes the
similarity between the individual ab initio models by the
normalized spatial discrepancy (NSD) [17]. The most
representative models (with the lowest average NSD) were
selected.
Chemicals
Except when indicated, all reagents were purchased from
Sigma-Aldrich (St. Louis, MO, USA).
Results
The CFTR regulatory domain is predicted
to be disordered
The bioinformatics analysis of RD predicted four disor-
dered regions, interrupted by three ordered regions, along
of the primary structure of the polypeptide. The residue
into the disordered regions are in intervals from 654 to 705,
from 716 to 768, from 773 to 792, and from 813 to 838.
The probability of disorder (threshold = 0.5) as predicted
by the metaPrDOS web server is shown in Fig. 1, were the
disordered regions are indicated by the bars. These disor-
dered regions represent 81 % of the sequence (149 out of
185 residues).
Preparation of recombinant CFTR regulatory domain
Human CFTR regulatory domain was expressed as inclu-
sion bodies, purified by chromatography and refolded in
vitro by two-step dialysis. The analysis of the protein by
SDS–polyacrylamide electrophoresis yielded a single band
at a molecular mass of about 24 kDa (Fig. 2a), which is
consistent with the molecular mass estimated from the
recombinant protein sequence. A further identification of
the purified protein was obtained from the Western-blot
assay (Fig. 2b), were a band strongly positive to the RD-
antibody was detected at a molecular mass of about
24 kDa. The quality of the refolding was checked com-
paring the fluorescence and CD spectra of the protein
before and after dialysis. The position of the peak of pro-
tein intrinsic fluorescence emission spectra of the unfolded
protein showed the maximum shifted to red as the protein
fluorophores are exposed to the polar environment. After
refolding, when protein fluorophores are accommodated in
the hydrophobic core of the protein, the fluorescence peak
shifts by 25 nm to left (Fig. 3a, b). The CD spectra also
Fig. 1 Primary structure analysis of CFTR-RD metaPrDOS predic-
tion of local disorder as a function of residue number. The disordered
regions are marked as horizontal lines. The threshold of 0.5 for the
probability of disorder shown in the figure was defined to obtain a
false-positive prediction rate \5 % (ROC = 0.904)
Fig. 2 Biochemical characterization of the recombinant RD prepa-
ration. a SDS–Polyacrylamide gel electrophoresis of the purified RD.
A molecular mass standard is shown. b Western-blot identification of
the CFTR-RD. The purified protein was revealed with a specific
monoclonal antibody
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changes from a predominant random coil for the unfolded
protein to a spectrum with secondary structure content for
the native RD (Fig. 3c).
Phosphorylation changes the RD conformation
The RD protein in solution retains a degree of secondary
structure organization, despite being intrinsically disor-
dered. This is evident from the CD spectra on Fig. 3c.
Deconvolution of the CD spectra for the native RD yielded
more than 30 % of random coil structure, but also the
presence of structured regions, with about 45 % of a-helix
and 12 % of b-sheet content. This secondary structure
composition is significantly altered when the protein is
phosphorylated. Deconvolving the corresponding CD
spectra (Fig. 3c; dark gray), we found a reduction of the
random coil structure, to about 18 %, and an increase of the
a-helix content to more than 70 %, and a dramatic reduc-
tion of b-sheet content to less than 1 %.
The conformational change of RD by phosphorylation is
also detected from the fluorescence spectroscopy assays.
Tyrosine-intrinsic fluorescence spectra were obtained upon
the excitation of the samples at 274 nm (Fig. 3a). The RD
construct has four tyrosine residues toward the N-terminus
of the polypeptide, composing the linker of the 6-His tag. A
further tyrosine is at CFTR-position 834 of RD, near to the
C-terminus of the polypeptide. Tyrosine 833 is not present
in this construct, as was substituted by leucine to increase
solubility [3]. Refolding of the protein caused a blue-shift
of the spectra, with an increase of the overall emission
intensity. This change is consistent with the re-accommo-
dation of the tyrosine fluorophores in a non-polar
environment, typical for a folded protein. However, phos-
phorylation does not modify the fluorescence spectra,
indicating that it does not introduce changes in the envi-
ronment of the tyrosines.
Conversely, phosphorylation produces a significant
modification of the emission spectra of the tryptophan.
When the protein is excited at 295 nm, the single trypto-
phan in the construct, at the CFTR-position 679, has an
emission fluorescence spectrum with a peak at 338 nm
(Fig. 3b). Phosphorylation of RD does not change the
position of the emission spectra, but increases the intensity
of fluorescence. This could be interpreted as the tryptophan
remaining in a non-polar environment, but a quencher
residue has moved from its neighborhood, increasing the
intrinsic fluorescence. This modification is consistent with
a conformational change, re-accommodating the lateral
chains of neighbor residues, and compatible with a sec-
ondary structure change.
In SEC experiments, the native RD eluted from the
column in a major peak that corresponds to apparent
molecular mass of 148 kDa and a Stokes radius
RS = 3.6 nm (Fig. 4). This molecular weight exceeds by
about sixfold that expected for a RD monomer. When the
RD is phosphorylated, the protein elutes at a significantly
smaller volume, corresponding to an apparent molecular
mass to 130 kDa, and a RS = 3.4 nm. These masses and
dimensions may correspond to aggregates, or to elongated
or unfolded proteins, which are known to elute at a volume
corresponding to a higher apparent molecular mass [2].
SAXS data was used to confirm the monomeric state of
the RD in solution. The molecular mass of the native, non-
phosphorylated, and the phosphorylated RD in solution
Fig. 3 Fluorescence and circular dichroism (CD) spectroscopy from
the native (black lines), phosphorylated (dark-gray lines) and
denatured (light-gray lines) RD. The fluorescence emission spectra
was obtained for excitation wavelengths of 274 nm (a), to reveal the
tyrosine and phenylalanine intrinsic fluorescence, and 290 nm (b), to
observe the tryptophan intrinsic fluorescence. The far-UV CD spectra
(c) were measured from 197 to 260 nm
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were estimated from the Guinier plot of the corresponding
SAXS spectra (Fig. 5, insert). The scattering intensity
extrapolated to s = 0 measured at each condition was
compared to that of the standard BSA sample [23], yielding
a molecular mass of 23.96 and 24.34 kDa, for the native
and the phosphorylated protein, respectively. This molec-
ular mass is consistent with that calculated from the
primary structure of the recombinant protein (23.3 KDa). It
confirms that this protein, is a monomer in solution, and the
Stokes hydrodynamic radius estimated from the SEC cor-
responds to that of a single RD molecule, either
phosphorylated or not.
The reduction of the size of the RD upon phosphoryla-
tion was also confirmed by the SAXS experiments. The
physical invariants measured from the SAXS spectra of the
native and the phosphorylated RD are presented in Table 1.
The radius of gyration, Rg, was measured with a higher
precision from the slope of the Guinier plot in Fig. 5.
There, an Rg value of 3.25 ± 0.18 and 2.92 ± 0.04 nm, for
the native and the phosphorylated RD, respectively, was
obtained. This data was further confirmed from the esti-
mation of Rg from the distance distribution function, P(r),
shown in Fig. 6. It is shown that the maximum distance,
Dmax, estimated from P(r) yielded a value of 11.4 nm for
the native RD, and 10.2 nm for the phosphorylated poly-
peptide. These differences in the size may be due to a
change in the shape of the molecule, as suggested com-
paring the P(r) presented in Fig. 6. In both cases, the form
of the distance distribution function is consistent with a
multilobular-elongated body, but the shape in the two states
is different [11]. Indeed, the particle volume estimated
from the Porod approximation yield similar values of about
72 nm3 (see Table 1).
Fig. 4 Size exclusion chromatography of the CFTR-RD. a The
chromatogram of the native (black line) and the phosphorylated (gray
line) RD. The molecular mass standards are shown as inverted
triangles; D dextran blue, AD alcohol dehydrogenase, AC carbonic
anhydrase, C cytochrome-C. b The square root of the partition
coefficient, Kav, is plotted against the Strokes radius, RS. The
calibration points are indicated as open circles. The native and the
phosphorylated RD are represented by a square and a triangle,
respectively
Fig. 5 The experimental X-ray scattering data fort the native (a) and
the phosphorylated (b) RD are shown as circles. Bars represent the
standard deviation of the measurement. The continuous dark-gray
lines are the scattering curve calculated from the inverse Fourier
transform in Fig. 6. The light-gray line is the scattering curve
calculated from the best optimization obtained from the EOM
analysis. The Guinier plot for each conformation is shown as an inset
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Solution model of the native and phosphorylated RD
The Kratky plot for either native or phosphorylated RD
(Fig. 7a) are not indicative of a compact, globular protein
(which is typically bell shaped) or a fully unfolded protein,
which would show a fast upward slope at higher scattering
angles. Instead, these plots show a first peak at approxi-
mately s = 0.6 nm-1, followed by several maxima,
without a net decrease in the function, suggesting that both
RD preparations, native and phosphorylated, are multi-
lobular and partially unfolded. The P(r) function of native
and phosphorylated RD have an asymmetric shape (Fig. 6),
with their maxima at low r followed by a long tail. This is
again consistent with an extended, perhaps partially
unfolded molecule with the maximum dimension (Dmax) of
11.4 and 10.2 nm for the native and the phosphorylated
RD, respectively.
Because the Kratky plot, P(r) function, and the dimen-
sion of the molecule (Rg and RS) indicated that the native
and the phosphorylated RD is partially unfolded, we used
an ensemble method (EOM) to quantitatively assess its
flexibility. The best EOM solution of ten independent runs
yielded very homogeneous v2-values of *1.3. We selected
the EOM ensembles with the best v2-value. The fit of the
EOM ensembles with the native and phosphorylated RD-
SAXS data are shown as a light-gray continuous line in
Fig. 5. The best EOM ensemble yielded a set of 16 and 19
models for the native and the phosphorylated RD, respec-
tively. Single models are presented in the supplementary
figures S1 and S2.
The width of the distribution of Rg and Dmax for the
EOM ensembles of the native and the phosphorylated RD
are smaller than that of the distribution of the random
Table 1 Physical invariants measured from the SAXS spectra of the native and the phosphorylated RD
Rg (nm) I(0) MM (kDa) Dmax (nm) Rg
* (nm) V (nm3)
Native 3.25 ± 0.18 4.38 ± 0.03 23.96 11.4 3.46 ± 0.03 71.2 ± 0.7
Phosphorylated 2.92 ± 0.04 4.45 ± 0.02 24.34 10.2 3.09 ± 0.02 71.99 ± 1.7
Rg and I(0) are the gyration radius and the extrapolation of the intensity to s = 0, respectively, calculated from the Guinier plot. MM is the
molecular mass estimated from I(0). Dmax and Rg
* are the maximum size of the particle and the gyration radius calculated from the distance
distribution function. V is the Porod volume of the particle
Fig. 6 P(r) distribution of the native (black line) and the phosphor-
ylated (gray line) RD. For comparison, the curves were normalized by
the area under the curve
Fig. 7 a Kratky plot of the native (black line) and the phosphorylated
(gray line) RD. Results of the EOM study showing the distribution of
the Rg (b) and Dmax (c). The distributions of the random pool are
shown in light gray, and those of the selected ensemble for native RD
are in black and for phosphorylated RD in dark gray
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population, indicating the procedure has selected an enri-
ched population of selected structures than the random pool
(Fig. 7b, c). The EOM ensemble for the native RD shows a
population (Fig. 7b) with a Rg average value of 3.44 nm,
which is bigger than the average Rg of the random popu-
lation of 3.38 nm. This is in agreement with the
distribution of Dmax, which indicates that the optimized
ensemble for the native RD has an average maximum size
that is larger than the random pool (Fig. 7c). Conversely,
the Rg of the EOM ensemble for the phosphorylated RD
has an average value of 3.06 nm, which is smaller than the
random population, consistent with a more compact
structure (Fig. 7b, c). The average head-to-tail distance of
the native RD, 7.6 ± 0.5 nm, is also larger than the aver-
age head-to-tail distance of the phosphorylated RD,
5.9 ± 0.5 nm. The overall different conformation, partic-
ularly on the extreme dimensions of the polypeptide, are
described by the residue-to-residue distance plot shown in
the supplementary figure S3. The average anisometry [5]
evaluated for all the EOM ensemble models was 2.1 ± 0.6
and 1.7 ± 0.3 nm, for the native and the phosphorylated
RD, respectively, indicating that the molecules have a
prolate shape, being the phosphorylated RD more compact.
Because the results from the CD and EOM analysis
provided evidence that native and phosphorylated RD
contains some structure and is not fully unfolded, we
performed ab initio modeling to visualize a suggestive
three-dimensional representation compatible with SAXS
data. Fifteen independent models for both native and
phosphorylated RD were generated by DAMMIF, and all
fit the corresponding experimental data well with v2-values
of *1.3 (Fig. 8a, b). The models align with an average
NSD value of 1.09 for the native RD and 0.781 for the
phosphorylated protein, indicating that the shape recon-
struction is more stable for the phosphorylated protein [33].
The most representative DAMMIF models are presented in
Fig 8c, d. Both models are characterized by an extended
shape formed by several lobules. The lobules in the native
RD model seem more defined, while they tend to be fused
for the phosphorylated RD. The average longest molecular
dimension of the native RD models is 11.8 ± 0.1, and
10.4 ± 0.1 nm for the phosphorylated RD, in agreement
with the Dmax obtained from the P(r) functions.
Discussion
From this combined biophysical study, a molecular view of
the CFTR regulatory domain, in the native and the phos-
phorylated state, is emerging. We compared the forward
extrapolation of the SAXS spectra of RD to that of a
standard bovine serum albumin to estimate the molecular
Fig. 8 Ab initio reconstruction
of the shape of the RD. The
continuous lines on the SAXS
data represents the calculated
scattering curves from
DAMMIF reconstruction of the
native (a) and the
phosphorylated (b) RD. Two
views of the ab initio bead
model of native (c) and the
phosphorylated (d) RD
calculated using DAMMIF. The
model shown is the most
representative of ten structures
calculated
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mass of our preparation [23]. For both native and phos-
phorylated RD the estimated molecular mass of the protein
in solution is *24 kDa (Table 1), that is about the
molecular mass calculated from the protein sequence. It
confirms that the RD is a monomer in solution, and that the
small partition coefficient measured by SEC is actually due
to the large RS of the protein, and not to some protein
aggregation during the chromatography experiments. On
the other hand, the Rg estimated from the Guinier plot of
the SAXS data yielded values that are consistent with the
RS values measured from SEC, and to those of non-glob-
ular proteins. Therefore, this protein domain in solution is
monomeric but its shape deviates greatly from globular,
and the bioinformatics analysis predicts that RD is an
intrinsically disordered protein. The hydrodynamic
behavior of the native and the phosphorylated RD, as
determined by SEC experiments, is intermediate between a
globular protein and a unfolded protein (Fig. 4). Indeed,
the expected RS a globular protein of a molecular mass of
24.3 kDa is about 2.1 nm, while the expected RS, an
unfolded protein (in 6 M guanidinium-HCl), is 4.4 nm
[35]. The RS of the native RD protein, 3.6 nm, is slightly
larger than the pre-molten state, that, for this protein is
predicted a RS = 3.4 nm. Phosphorylation of RD produces
a slight compacting of the molecule, observed as a small
reduction of RS to 3.4 nm, which is also in the range cor-
responding to a pre-molten protein. Hence, we can
hypothesize that it contains some local structure and is
moderately compact but lacks a folded core, characteristic
of an intrinsically disordered protein.
Interestingly, some organized secondary structure is
detected by CD analysis. We interpreted the relative
abundance of the predicted secondary structure from CD
results with caution given that current methods of CD
spectral deconvolution are not ideally adaptable to proteins
with a large degree of disorder because the reference dat-
abases consist mainly of globular folded proteins [41]. This
could explain the differences in the interpretation of the
secondary structure contents or native and phosphorylated
RD reported by others [3, 9]. Nevertheless, comparison
between CD spectra from folded and the unfolded proteins
(Fig. 3c) clearly confirms the secondary structure contents
of the signal. Indeed, a partially disordered protein does
contain some amount of secondary structure, at difference
to a denatured protein, which presents only the random coil
conformation (for a review, see [8, 28, 37]). More inter-
estingly, there is a reproducible net difference between the
CD spectra from native and phosphorylated RD (see Fig.
3c). This difference reveals a conformational change of RD
induced by phosphorylation. The RD phosphorylation
conditions applied here induces the maximal change on the
CD spectra, as previously demonstrated [19], and therefore
we could consider a bona fide maximum phosphorylation
condition of the protein. In this condition of maximum
phosphorylation, it is expected to find at least eight phos-
phoserines in the RD (residues 660, 700, 712, 737, 753,
768, 795, and 813 of the CFTR), as determined by mass
spectroscopy [24, 36] and NMR analysis [3]. A further
serine in position 670 has been reported to be partially
(&60 %) phosphorylated [18].
Fluorescence spectroscopy has also shown a difference
between the unfolded RD in 6 M guanidinium-HCl and the
folded protein after the dialysis procedure, confirming the
difference between the completely unfolded state and the
native protein (Fig. 3a, b). These experiments have also
shown that the intrinsic tryptophan fluorescence increases
when the RD is phosphorylated (Fig. 3b). The lower
intrinsic fluorescence in the native state may be due to a
quenching of the tryptophan fluorescence by negatively
charged residues that are rearranged upon a conformational
change produced by the RD phosphorylation.
SAXS experiments have confirmed the molecular
changes produced by the phosphorylation. The shape of the
distance distribution functions, P(r), calculated from the
SAXS data have a maximum that is smaller than Dmax/2
(Fig. 6), which correspond to elongated molecules [10, 34].
Consistently, the ab initio molecular shape reconstructed
from the SAXS data results in elongated molecules for both
native and phosphorylated RD (Fig. 8). Moreover, the
EOM ensembles were also characterized with an anisom-
etry larger than 1, which is consistent with an elongated
prolate shape of the molecules. The EOM analysis also
indicated differences between the ensembles for the native
and phosphorylated RD. Indeed, the phosphorylated RD
has a smaller average Rg and Dmax than the native protein
(Fig. 7b, c). The best EOM ensembles, which account for
the continuous light-gray lines in Fig. 5, are composed by
16 and 19 structures for the native and phosphorylated RD
(see supplementary figures S1 and S2).
The experiments reported here demonstrate conclusively
that the CFTR RD is best described as being in the pre-
molten globule state, in agreement with the definition of a
partially disordered protein resulted from the bioinformat-
ics analysis, and from the previous studies by NMR [3].
The characteristics of the molten globule are that it has
similar secondary structural elements with the native fol-
ded state, but the tertiary interactions are absent; the
protein remains globular but loosely packed.
Some disordered regions of proteins can form structure
on binding to targets [20]. Therefore, we cannot rule out
the possibility that when the RD form part of the whole
CFTR protein, the interactions with other protein domains
may restrict the degree of disorder observed on the isolated
proteins in solution. Unfortunately, at the moment we do
not have enough data to predict what is the actual con-
formation of RD in the whole protein. Available NMR data
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[3, 16], as well as other data regarding domain–domain
interactions (see for example [42]) has been obtained from
isolated domains in solution, lacking the topological
restraints of the whole protein anchored in a membrane.
Perhaps these data could be used as restraints to dock the
RD models obtained here with a consensus between the
available molecular homology models [1, 7, 21, 22, 25,
29], together with the structural data, as that obtained from
cryo-electron microscopy models [44, 45], to get a
plausible image of the CFTR intracellular domains orga-
nization. It is, however, important to notice that the
conformational changes observed in the isolated proteins
may be related with the possible different interactions of
RD with NBDs for the activated and the inactivated CFTR.
It is conceivable that its conformational variability offers
RD the advantage of adaptive binding to its targets into the
CFTR protein. Here, we have presented the first experi-
mental-based set of molecular models for the CFTR
regulatory domain. Our biophysical characterizations of
this protein, along with the low-resolution solution model,
will pave the way for studying the molecular interactions of
RD with other parts of CFTR, which have many implica-
tions on the understanding the pathophysiology of cystic
fibrosis.
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